Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Robotically implanted Neuralink N1 brain-computer interface to control external devices

Official title: GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

Run by Neuralink Corp · NCT07127172 · Data updated 2026-11-12

This study will test whether a robotically implanted Neuralink N1 brain-computer interface can safely help people with high spinal cord injuries or ALS control computers and other external devices.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment7 (estimated)
SponsorNeuralink Corp
Industry-sponsored
Locations2 sites (London, Greater London and 1 other locations)
StatusRecruiting
StartedJuly 31, 2025
Main results expectedJanuary 2028
Study endsFebruary 2031
Registry record updatedAugust 17, 2025
Trial IDNCT07127172 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with non-ambulant bilateral upper-limb motor impairment from cervical spinal cord injury, brainstem stroke, or progressive conditions like ALS who are expected to reach severe tetraparesis, have life expectancy ≥12 months, can communicate in English, and have a stable caregiver.

Probably not a fit

Patients who are at high perioperative risk, have active implanted devices, morbid obesity (BMI > 40), very limited life expectancy, inability to communicate in English, or no reliable caregiver are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an early feasibility clinical study to examine the safety and functionality of the Neuralink N1 implant and the R1 robotic insertion system in people with severe upper-limb paralysis. The N1 is a wireless, rechargeable device mounted on the skull and connected to thin electrode threads that the R1 Robot inserts into the brain. Eligible participants have tetraparesis or tetraplegia from spinal cord injury, brainstem stroke, or progressive conditions such as ALS and will undergo robot-assisted implantation followed by training and regular follow-up visits. Outcomes will focus on perioperative safety, device performance, and the participant's ability to use the implant to control external devices while monitoring for adverse events.

Why it matters

Potential benefit: If successful, the device could restore hands-free control of phones, computers, and assistive technology and increase independence for people with severe upper-limb paralysis.

How similar studies have gone: Prior intracortical brain-computer interface studies using implanted microelectrode arrays have shown proof-of-concept for device and cursor control in small groups, but a fully wireless, robotically implanted system like the Neuralink N1 is novel and early in clinical testing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* (a) A diagnosis of a spinal cord injury, brain stem stroke, or other neurological condition causing the participant to be non-ambulant and with bilateral upper limb motor impairment with no expectation of recovery that significantly or completely impairs the participant's ability to manually control a computer, smartphone or tablet with their hands.

OR (b) A diagnosis of Amyotrophic Lateral Sclerosis (ALS) or other progressive neurological condition where the natural history of the disease is well understood and where there is tetraparesis and the expectation in the view of the participants treating neurologist that the disease will progress such that the participant will meet 1a within 1 year of recruitment.

* Life expectancy ≥ 12 months.
* Ability to communicate in English
* Presence of a stable caregiver

Exclusion Criteria:

* Moderate to high risk for serious perioperative adverse events
* Active implanted devices
* Morbid obesity (Body Mass Index \> 40)
* History of poorly controlled seizures or epilepsy
* History of poorly controlled diabetes
* Requires magnetic resonance imaging (MRI) for any ongoing medical conditions
* Acquired or hereditary immunosuppression
* Use of smoking tobacco or other tobacco products
* Psychiatric or psychological disorder
* Brain MRI demonstrating hemorrhage, tumor, distorted or adverse anatomy.
* Any condition which, in the opinion of the Investigator, would compromise your ability to safely participate in the study or undergo the implantation procedure

Where it's running

  • University College London Hospitals NHS Foundation Trust
    London, Greater London, United Kingdom
    Recruiting
  • The Newcastle upon Tyne Hospitals NHS Foundation Trust
    Newcastle upon Tyne, Tyne and Wear, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.